Elenco degli articoli con argomento «dermatite atopica»
Dermatologia04 mar 2021
A 48-week update
A 48-week update of a multicentre real-life experience of dupilumab in adult patients
24 feb 2021
A Short Cycle of Narrow-Band UVB
Since the best clinical response to dupilumab is achieved after 12-16 weeks
15 feb 2021
Skin Barrier Function in Psoriasis and Atopic Dermatitis
Multiple diagnostic tools are used to evaluate psoriasis and atopic dermatitis (AD) severity, but most of them are based on subjective components.
13 gen 2021
Hidradenitis Suppurativa and Atopic Dermatitis: A Two-Way Association
The co-existence of hidradenitis suppurativa (HS) and atopic dermatitis (AD) had been reported but was not investigated in controlled studies.
21 dic 2020
Piattaforma Accurate
Raccolta dei dati relativi all’Uso Compassionevole di UPADACITINIB in Dermatite Atopica
24 nov 2020
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
Atopic dermatitis is a common, chronic, immune-mediated disease associated with several comorbidities.
11 nov 2020
Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis
Real‐world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single centre, prospective one‐year observational cohort study of the first 100 patients treated
20 ott 2020
Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
Dupilumab, an inhibitor of interleukin (IL)‐4/13 activity, is a biological agent approved for the treatment of moderate‐to‐severe atopic dermatitis (AD)
20 ott 2020
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis
Is exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?
06 ott 2020
What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice?
A prospective observational study
22 set 2020
Tuscan Consensus on the diagnosis, treatment and follow up of adult atopic dermatitis
Atopic dermatitis (AD) is an inflammatory disease with a chronic-relapsing course that is intensely itchy.
14 set 2020
A phase 2, open‐label study of single dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis
pharmacokinetics, safety and efficacy
15 lug 2020
Current and emerging treatments targeting the neuroendocrine system for disorders of the skin and its appendages.
The skin as a neuroendocrine organ and the role of neuroendocrine signaling in the development of disorders affecting the skin and its appendages has received increasing attention in the last years.
17 giu 2020
Atopia Visita Virtuale
Sono lieta di comunicarvi che, da oggi fino alla fine del 2020, è attivo il servizio di videoconsulto gratuito «Atopia Visita Virtuale» promosso dalla nostra Società e realizzato in collaborazione con Paginemediche, piattaforma di salute digitale.
15 giu 2020
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo
Chronic nodular prurigo (CNPG) is a multifactorial skin disease characterized by itchy papules and nodules, usually resistant to standard treatment and associated with markedly impaired quality of life.
10 mag 2020
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis
A Systematic Review and Network Meta-analysis
31 mar 2020
Biologicals in atopic disease in pregnancy: an EAACI position paper
an EAACI position paper
24 mar 2020
Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis
results from a phase IIa open‐label trial and subsequent phase III open‐label extension
17 feb 2020
Atopic dermatitis and the metabolic syndrome: a cross-sectional study of 116 816 patients.
Data regarding the association between atopic dermatitis (AD) and the metabolic syndrome are controversial.
07 gen 2020
Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience
Atopic dermatitis (AD) is one of the most common cutaneous inflammatory diseases both in adults and in children.